Martin Edelman, MD

Professor, Chair, Department of Hematology/Oncology, G. Morris Dorrance Jr. Chair in Medical Oncology, Associate Cancer Center Director for Clinical Research Integration, Chair, Department of Medical Oncology, Lewis Katz School of Medicine at Temple University

Cancer Signaling and Microenvironment (CSM)
Chair, Department of Hematology/ Oncology, Hematology Oncology

https://orcid.org/0000-0002-3752-0726

h-index
h10-index
h5-index

Research activity per year

193 Article
31 Review article
13 Comment/debate
3 Chapter
More

3 results

Filter

2017
Highlights in the treatment of lung cancer What's new? Not much
Edelman, M. J., Mar 2017, In: JAMA Oncology. 3, 3, p. 301-302 2 p.
Research output: Contribution to journal › Short survey › peer-review
2 Scopus citations
2013

Resistance to anti-angiogenic agents: A brief review of mechanisms and consequences
Edelman, M. J. & Mao, L., 2013, In: Translational Lung Cancer Research. 2, 4, p. 304-307 4 p.
Research output: Contribution to journal › Short survey › peer-review

7 Scopus citations
1998
Follow-up testing after cancer treatment: Is it indicated?
Edelman, M. J., Siegel, D. & Meyers, F., 1998, In: Western Journal of Medicine. 168, 6, p. 528-529 2 p.
Research output: Contribution to journal › Short survey › peer-review
2 Scopus citations

Martin Edelman, MD

Research output

Search results

Highlights in the treatment of lung cancer What's new? Not much

Resistance to anti-angiogenic agents: A brief review of mechanisms and consequences

Follow-up testing after cancer treatment: Is it indicated?